1987
DOI: 10.1159/000457774
|View full text |Cite
|
Sign up to set email alerts
|

Beta-Adrenergic Binding Sites in Fetal Rat Central Nervous System and Pineal Gland: Their Relation to Other Receptor Sites

Abstract: Regional development of β-adrenergic binding sites in the rat fetal central nervous system and pineal gland were studied in relation to the ontogeny of different drug and neurotransmitter binding sites. 3H-dihydroalprenolol labels the olfactory bulb very early in fetal life. A comparatively early development of binding sites is also seen for benzodiazepines during late gestation. 3H-serotonin, 3H-muscimol, 3F1-GABA and 3H- (N)-methylscopolamine additionally label the olfactory bulb, revealing quite different p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
10
0

Year Published

1992
1992
2007
2007

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(10 citation statements)
references
References 20 publications
0
10
0
Order By: Relevance
“…Neurotransmitters are thought to play a role as growth factors, with b-adrenergic agonists inhibiting proliferation while promoting differentiation. 2 Work with rodents shows that functional b-adrenergic receptors are expressed in the central nervous system during gestation, 3,4 and research on the effects of exposure to terbutaline, a b 2 -adrenergic receptor agonist, has produced evidence that pharmaceutical stimulation of the receptor in the fetus alters patterns of brain development [5][6][7][8] and could potentially increase risk for autism. 9 This suggests that other factors increasing stimulation of this receptor and the ensuing pathways, including functional polymorphisms in the receptor gene (ADRB2, also known as B2AR), may affect neurodevelopment and be associated with increased risk for autism.…”
Section: Introductionmentioning
confidence: 99%
“…Neurotransmitters are thought to play a role as growth factors, with b-adrenergic agonists inhibiting proliferation while promoting differentiation. 2 Work with rodents shows that functional b-adrenergic receptors are expressed in the central nervous system during gestation, 3,4 and research on the effects of exposure to terbutaline, a b 2 -adrenergic receptor agonist, has produced evidence that pharmaceutical stimulation of the receptor in the fetus alters patterns of brain development [5][6][7][8] and could potentially increase risk for autism. 9 This suggests that other factors increasing stimulation of this receptor and the ensuing pathways, including functional polymorphisms in the receptor gene (ADRB2, also known as B2AR), may affect neurodevelopment and be associated with increased risk for autism.…”
Section: Introductionmentioning
confidence: 99%
“…These [4,20]. The [27,28] to low levels in adulthood [8,19,35] [13]. More likely, activation of mAChRs may play a regulatory role in the development of the pineal gland, in general, and in the maturation of the melatonin-generating system, in particular.…”
mentioning
confidence: 99%
“…Approximately one-third of the norepinephrine in the olfactory bulb is observed in the more superficial layers of the bulb (Nadi et al, 19801, and the highest concentration of norepinephrine in the bulb is found in the external plexiform layer (Jaffe and Cuello, 1980). Several studies have observed comparatively low densities of beta-adrenergic receptors (BARS) in the olfactory bulb of embryonic (Schlumpf et al, 1987) and adult mammals (Nadi et al, 1980;Palacios and Kuhar, 1982;Booze et al, 1989;Wanaka et al, 1989). None of these studies, however, have analyzed carefully the beta-adrenergic receptor density in the olfactory bulb postnatally with quantitative methods.…”
mentioning
confidence: 99%